Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rvl Pharmaceuticals Plc (RVLPQ)
:RVLPQ
Holding RVLPQ?
Track your performance easily
RVLPQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume2.10K
Average Volume (3M)23.64K
Market Cap
$111.00
Enterprise ValueN/A
Total Cash (Recent Filing)$19.56M
Total Debt (Recent Filing)$323.74M
Price to Earnings (P/E)―
Beta334.79
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding111,406,044
10 Day Avg. Volume279
30 Day Avg. Volume23,637
Standard Deviation21.80
R-Squared0.00458
Alpha4.47
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RVL Pharmaceuticals News
PremiumCompany Announcements
RVL Pharmaceuticals Ordered to Liquidate by Irish High Court
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
13.86% Other Institutional Investors
86.14% Public Companies and
Individual Investors
RVLPQ FAQ
What was Rvl Pharmaceuticals Plc’s price range in the past 12 months?
Currently, no data Available
What is Rvl Pharmaceuticals Plc’s market cap?
Rvl Pharmaceuticals Plc’s market cap is $111.00.
When is Rvl Pharmaceuticals Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rvl Pharmaceuticals Plc’s earnings last quarter?
Currently, no data Available
Is Rvl Pharmaceuticals Plc overvalued?
According to Wall Street analysts Rvl Pharmaceuticals Plc’s price is currently Overvalued.
Does Rvl Pharmaceuticals Plc pay dividends?
Rvl Pharmaceuticals Plc does not currently pay dividends.
What is Rvl Pharmaceuticals Plc’s EPS estimate?
Rvl Pharmaceuticals Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rvl Pharmaceuticals Plc have?
Rvl Pharmaceuticals Plc has 111,406,044 shares outstanding.
What happened to Rvl Pharmaceuticals Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rvl Pharmaceuticals Plc?
Currently, no hedge funds are holding shares in RVLPQ
---
Company Description
Rvl Pharmaceuticals Plc
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development and commercialization of specialty products for neurology and women's health. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
---
RVLPQ Earnings Call
Q2 2023
0:00 / 0:00
---
Avadel Pharmaceuticals
―
Evolus
―
MannKind
―
Relmada Therapeutics
―
Trevena
―
AstraZeneca
―
---